Novabridge BiosciencesNBP
13F holders, Q1 2024 (March 31)39holders
2famous investors
$1.86avg. 13F price*
At the end of Q1 2024, 39 institutions reported holding Novabridge Biosciences (NBP) in their 13F filings. The largest holders were HHLR Advisors, LTD. ($12.9M), Caligan Partners LP ($1.4M) and Two Sigma Advisers, LP ($1.1M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Novabridge Biosciences
- Filed as
- I MAB (Q1 2024)
- CUSIP
- 44975P103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $2.9M |
| Exits | 11 | $2.0M |
Ownership 39 holders
| HHLR Advisors, LTD. | 0.28% | No change | 6,909,220 | $12.9M |
| Caligan Partners LP | 0.37% | New | 756,538 | $1.4M |
| Two Sigma Advisers, LP | 0.00% | Add +10.4% | 617,100 | $1.1M |
| Two Sigma Investments, LP | 0.00% | Add +0.1% | 575,580 | $1.1M |
| Temasek Holdings (Private) Ltd | 0.01% | No change | 566,650 | $1.1M |
| Gsa Capital Partners LLP | 0.06% | Reduce -19.6% | 432,621 | $805K |
| Boothbay Fund Management, LLC | 0.02% | New | 378,269 | $704K |
| Exome Asset Management LLC | 0.52% | New | 325,762 | $606K |
| EDBI Pte Ltd | 0.46% | No change | 222,136 | $413K |
| Aberdeen Group plc | 0.00% | No change | 162,580 | $302K |
| Catalyst Funds Management Pty Ltd | 0.08% | — | 146,290 | $272K |
| Man Group plc | 0.00% | Add +22.0% | 134,977 | $251K |
| State Street Corp. | 0.00% | Add +8.5% | 110,373 | $205K |
| Millennium Management | 0.00% | Reduce -51.1% | 93,508 | $174K |
| Invesco Ltd. | 0.00% | Add +330.8% | 85,144 | $158K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -41.5% | 84,941 | $158K |
| Prelude Capital Management, LLC | 0.01% | Add +142.2% | 81,262 | $151K |
| Alberta Investment Management Corp | 0.00% | No change | 74,723 | $139K |
| Marshall Wace, LLP | 0.00% | New | 71,088 | $132K |
| Renaissance Technologies | 0.00% | No change | 63,800 | $119K |
| Dimensional Fund Advisors LP | 0.00% | Add +67.2% | 60,407 | $112K |
| Barclays PLC | 0.00% | Reduce -77.7% | 38,552 | $72K |
| Geode Capital Management, LLC | 0.00% | No change | 34,347 | $64K |
| Mariner, LLC | 0.00% | Add +131.9% | 31,535 | $59K |
| XTX Topco Ltd | 0.01% | Reduce -15.2% | 30,485 | $57K |
| Donald L. Hagan, LLC | 0.03% | No change | 30,000 | $56K |
| Atom Investors LP | 0.01% | New | 29,612 | $55K |
| Bank of America Corp. | 0.00% | Reduce -55.6% | 18,857 | $35K |
| Morgan Stanley | 0.00% | Reduce -98.0% | 10,109 | $19K |
| BlackRock Inc. | 0.00% | Reduce -92.1% | 7,923 | $15K |
| Qube Research & Technologies Ltd | 0.00% | Add +87.5% | 4,065 | $8K |
| Royal Bank of Canada | 0.00% | No change | 1,644 | $3K |
| Rhumbline Advisers | 0.00% | No change | 1,371 | $3K |
| UBS Group AG | 0.00% | Reduce -91.3% | 1,331 | $2K |
| Legal & General Group Plc | 0.00% | No change | 1,191 | $2K |
| Frazier Financial Advisors, LLC | 0.00% | Add +25.0% | 375 | $698 |
| GAMMA Investing LLC | 0.00% | No change | 63 | $117 |
| Citigroup Inc. | 0.00% | No change | 50 | $93 |
| Simplex Trading, LLC | 0.00% | Add +2000.0% | 84 | $0 |
"% of holder's portfolio" is NBP's weight in each manager's 13F, not the share of Novabridge Biosciences the manager owns.